Home › Steatotic Liver Disease › Louisiana

Pag-aaral pangklinika para sa Steatotic Liver Disease sa Louisiana

11 pag-aaral para sa Steatotic Liver Disease ang naghahanap ng mga kalahok sa mga site sa Louisiana.

Mga Lungsod sa Louisiana

Opisyal na teksto ng pag-aaral (English)

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

89bio Clinical Study Site, Lafayette
89bio Clinical Study Site, Lake Charles
89bio Clinical Study Site, West Monroe

Nagre-recruitPhase 3

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

89bio Clinical Study Site, Covington
89bio Clinical Study Site, Houma
89bio Clinical Study Site, Lake Charles
at 2 pa

Nagre-recruitPhase 3

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06318169

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Tandem Clinical Research, Plaza II, Metairie

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07527910

A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition

Tandem Clinical Research, Metairie

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05519475

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

Delta Research Partners of Bastrop, LLC, Bastrop
Tandem Clinical Research, Marrero
Care Access - New Iberia, New Iberia
at 2 pa

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Akero Clinical Study Site, Bastrop
Akero Clinical Study Site, Covington
Akero Clinical Study Site, Houma
at 5 pa

Nagre-recruitPhase 3

Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

GSK Investigational Site, Marrero

Nagre-recruitPhase 3

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07221188

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Tandem Clinical Research, Covington
Tandem Clinical Research, Houma
Tandem Clinical Research GI, LLC, Marrero
at 4 pa

Nagre-recruitPhase 2

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07288138

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

GSK Investigational Site, Marrero

Nagre-recruitPhase 2

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT06613698

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

GSK Investigational Site, Bastrop
GSK Investigational Site, Marrero

Nagre-recruitPhase 3

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT07221227

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Tandem Clinical Research, Marrero

Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT05648214

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.